In my opinion, <u>natural gas</u> is a source that will be most common in the future. Considering that natural gas is a fossil fuel that is used as a source of energy for heating, cooking, and electricity generation. It is also used in stoves, ovens, clothes dryers, lighting fixtures and other appliances that are used and needed in everyday life. Imagine a life without natural gas. We wouldn't be able to heat our homes, cook our food, etc.
Hydrogen is more frequently bonded with Carbon.
It’s called a slump
Hope this helps :)
Answer:
The correct pair is A: "apicomplexans—parasites of animals"
Explanation:
- Euglenophyta is a group of unicellular, eukaryotic organisms. They are small, free-living forms, or parasites that present different feeding mechanisms and behaviors, such as heterotrophy, autotrophy, or mixotrophy.
- Dinoflagellates are unicellular, flagellated, free-living protists that might form colonies. Most of them are autotrophic organisms but some of them are heterotrophic, or mixotrophic. In these last cases, dinoflagellates can feed on other dinoflagellates, protozoans, or diatoms. They can also be parasites.
- Entamoebas are endoparasitic organisms with no mitochondria as an adaptation of living in environments with low oxygen concentration.
- Apicomplexa is a unicellular, protist group. They have medical and economic importance as they are<u> animals</u> and human parasites. They have an apical complex that helps them to fixate to the host cell and release a substance that provokes an invagination in the host membrane. This invagination allows the parasite to get into the host cell.
The post-eradication era is a period of history for which there has been no precedent whatsoever in terms of a zero base of immunity. Cessation of immunization will eventually create a population susceptible to widespread infection in the event of accidental or intentional reintroduction or re-emergence of the eradicated virus. Thus, even after immunization ceases, vaccine production must continue.
However, many currently available vaccines may not be appropriate for continued post-eradication vaccine production or reinstatement. Vaccines must be continually improved and ongoing vaccination research maintained. Other potentially useful antiviral strategies—antivirals, prophylaxis, and probiotics—must also be considered as means to strengthen the immune system and serve as adjuvant or prophylactic therapies.
In the case of polio, for example, it remains to be determined which vaccine (oral polio vaccine [OPV] or inactivated polio vaccine [IPV]), or variant thereof, should be produced in the post-eradication, post-vaccination era. A detailed plan for vaccine production will require more information on OPV-derived viral persistence and transmission, as well as continuing dialogue between public health and research communities in order to ensure that appropriate vaccination research continues.
